Jan 09, 2024 / 05:00PM GMT
Unidentified Participant_1
Yeah. Good morning, everyone. Welcome to the 42nd edition of the JPM Healthcare Conference in San Francisco. I'm happy to introduce you to Carlos Gallardo, Chairman and CEO of Almirall. Thank you.
Carlos Gallardo PiquéAlmirall - S.A. - President & CEO
Thank you, Niccolo, and good morning, everyone. It's a pleasure to be here with all of you, and thanks to JPMorgan for the kind invitation one more year.
So almost 10 years ago, we took the strategic decision to focus exclusively on medical dermatology. So we started our journey to build our portfolio and to build a pipeline in this indication. Today, I'm very happy to share with you that we are a recognized leader in Europe, already in medical dermatology with a strong portfolio of 48 products and across different modalities: topical, systemics, and biologics.
We have a strong commercial organization that cover 60% of office-based dermatologists in Europe and 90% of hospital-based dermatologist and a growing and exciting pipeline also across different
Almirall SA at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot